~ Welcome to Brave-Souls.com ~
(Note: Use back arrow to return here if there is no return link)

  • In Memory of Josefina Cua
  • Message from Stanley, the website host

  • Speak-with-Survivors
  • More Testimonials
  • Cancer Related Websites

  • Updates on CDA-II
  • Integrated TCM Therapy
  • PolyMVA Therapy

  • Important Message for California Residents

    Chinese Version Brave-souls
    Chinese Version Brave-souls

    Some Alternative Weapons with Testimonials to Fight Cancer:
    (Use back arrow to return here if there is no return link)

    Gerson Therapy
    Hoxsey Therapy
    High Dose Vitamin C Supplement
    Integrated Traditional Chinese Medicine (Integrated TCM)

    More to Come

    (Practitioners of alternative cancer treatments who have successful testimonials are welcomed to send their experience for publication on this section)

  • 32 Selected Western Herbs Against Cancer
  • 6 Classifications of Chinese Herbs Used in The Treatment of Cancer
  • Chinese herbs used in 13 common types of cancer

    Nutritional and Herbal Approach to Better Health:
    (Use back arrow to return here if there is no return link)

    Binzel Nutritional Program

    Nutritional Approach
    (presently under construction, will be available soon)
    Natural Diet
    (presently under construction, will be available soon)
    (presently under construction, will be available soon)

    Update (April, 2004) on the approval of third clinical trial of CDA-II

    The third clinical trial of CDA-II has been approved by the Chinese government, which means that it can be sold commercially, and will soon be available to all hospitals and clinics in China probably before August, 2004.

    CDA-II is an extract of the human urine, principally from school children. It contains lower molecular weight fractions of peptides that have been found to reverse various types of cancer. It doesn't kill the cancer cells, but converts the cancer cells back to normal cells. Technically it is a cell differentiation therapy. Normally, human cells have a cycle of being born, passing through young age, adolescence, old age, and finally death. Cancer cells do not follow the life cycle of normal cells, that is, some of them stay longer in young age, some in adolescence, some in old age, so that they live much longer than the normal cells in one cycle. In other words, they do not die like normal cells do. However, they behave almost like normal cells, that is why it is so difficult to kill them by conventional chemotherapeutic drugs without killing the normal cells at the same time. CDA-II, like the anti-neoplastons pioneered by Dr. Burzynski in USA in the late 1970s, and is still under investigation by the FDA at present, induces the cancer cells into normal cycle from birth to death. According to Dr. Ming Liau, who developed the CDA-II, an abnormal methylation process in the formation of cancer cells is being interrupted by CDA-II, so that the cancer cells are being induced back to normal cells, and go through the normal cycle from birth to death.

    For a brief history of the development of CDA-II, read History Of CDA-II for basic information (Use back arrow to return here if there is no return link).

    On the left are the CDA-II inventor, Dr. Ming C. Liau (left), the 3rd clinical trial overall coordinator, Lady Dr. Wen-Xia Huang (middle), and the creator of this website, Stanley Cua (right), photo taken in Shanghai, August 27, 2002.

    For a brief history of CDA-II, read History Of CDA-II for basic information (Use "Back" arrow to return here).

    Below are two long-term survivors who used CDA-II

    On the left is Mr. Yi-Qin Cheng, age 57 (left) with Dr. Ming C. Liau (right). Mr. Cheng was diagnosed primary liver cancer in 1994 and had surgery to remove the liver tumor. Two years later, cancer recurred with eight tumors in the liver, the largest had 2.4 cm diameter. Mr. Cheng chose CDA-II therapy because there were too many tumors for the surgery. He was given 15 days of infusion of CDA-II solution as one treatment. He had a total of 3 treatments with 7 days of rest between the treatments. All eight tumors disappeared after 3rd treatment. Mr. Cheng continued to take 25 capsules daily of oral CDA-II for the next 3 years to prevent the recurrence. The dosage was then reduced to 5 capsules daily afterwards. His dosage now is reduced to 5 capsules in 2 days, and he is now on his 6th year of survival after the CDA-II therapy. Viewers who wish to communicate with him for more information can contact me for his phone. He is now the manager of a construction company in Shanghai.

    On the left is Mr. Hui-Quan Xue, age 82 (left) with the doctor who treated him, Dr. Po-Shou Xu (right). Mr. Xue was diagnosed lung cancer in 1996. He was treated with 6 weeks of combined radiation therapy and CDA-II. The tumor size was reduced by 50% after the combined therapy. The tumor was stabilized in the next 6 months. He then requested further treatment with CDA-II for 6 weeks. The tumor was basically removed. He is now (2002) cancer-free for 6 years

    Update (September, 2002) on the completed third clinical trial of CDA-II enrolling about 450 patients of liver, lung and breast cancer in 12 hospitals in China

    By Stanley Cua, September 21, 2002

    The 3rd clinical trial started in September, 2001, and ended in August, 2002. The duration of treatment was about 8 weeks for each patient. The objective of the 3rd clinical trial was to compare the tumor size reduction between using chemotherapy alone and using combination of chemotherapy and CDA-II. The types of cancer in the clinical trial were liver, lung, and breast cancer.

    If CDA-II is considered an alternative cancer therapy, this clinical trial is probably the largest documented alternative cancer therapy clinical trial. It involved about 450 patients and 12 large hospitals in China. Every patient had documented CT scan before and after the treatment. The clinical trial not only measured the tumor size reduction, but also the quality of life of the patient using the European EORTC system of QLQ-C30 (V3.0). Both primary and metastasized were included. Many were terminal cases. Only about 35% of the results of total patients are reported here, the remaining will be reported later after the evaluation.

    CDA-II is an extract from human urine. Its anti-cancer property has been demonstrated in similar product antineoplastons and many anecdotal reports in urine therapy in Asia. Using urine therapy, CDA-II, laetrile, and vitamin C with Gerson-type diet from 1996 to 1997, Dr. Kamataro Sano at Sano Surgical Hospital in Kofu City near Tokyo had achieved an amazing 9% total remission, 35% tumor size reduction of more than half of the original, 28% tumor size reduction of less than half of the original in 46 patients (a total of 72% of effective tumor reduction).

    One of the hypotheses advanced by Dr. Liau is the effect of methionine in cancer cell differentiation. Methionine obstructs the differentiation of cancer cells, thus allowing cancer cells to live much longer than the normal cells. Ordinary meats from the animals are much higher in methionine content compared to vegetables, grains and fruits. This is one of the reasons why a vegetarian diet helps in cancer treatment. This is a very interesting hypothesis. It was discovered by Dr. Liau in his earlier research projects funded by National Cancer Institute and Welch Foundation some 30 years ago (see History of CDA-II in Learn-From-Others webpage). Dr. Liau thinks that methionine content may be a cancer marker in the treatment that uses cell differentiation agent such as CDA-II. With the success of CDA-II in this 3rd clinical trial, it is hoped that Dr. Liau's hypothesis can be verified by other researchers.

    The 12 hospitals involved in the 3rd clinical trials are (The English name here are literally translated. The Chinese names are shown on the right)

  • Chinese Medical Science Institute Cancer Hospital
  • Fujian Province Cancer Hospital
  • Beijing 301 Hospital
  • Tianjin Medical School Cancer Hospital
  • Shanghai Medical School Cancer Hospital
  • Sian Medical School First Hospital
  • 4th Military District Medical School Sijing Hospital
  • Talian Medical School Second Hospital
  • Pangpu Medical School Cancer Hospital
  • Beijing Hospital
  • Beijing Pulmonary Cancer Hospital
  • 2nd Military District Medical School Changhai Hospital
  • The results of about 160 patients of the 3rd clinical trial are shown here. Complete results are being evaluated at present, and will be reported when completed.

    For chemotherapy alone:

  • number of patients evaluated = 47
  • Complete tumor reduction = 1 patient (2.1%)
  • Partial tumor reduction (50% or more reduction) = 4 patients (8.5%)
  • Partial tumor reduction (25% to 50% reduction) = 3 patients (6.4%)
  • Tumor stabilized = 29 patients (61.7%)
  • Patient deteriorated = 10 patients (21.3%)

    For combined chemotherapy and CDA-II:

  • number of patients evaluated = 104
  • Complete tumor reduction = 1 patient (1.0%)
  • Partial tumor reduction (50% or more reduction) = 19 patients (18.3%)
  • Partial tumor reduction (25% to 50% reduction) = 10 patients (9.6%)
  • Tumor stabilized = 61 patients (58.6%)
  • Patient deteriorated = 13 patients (12.5%)

    The overall result in this partial evaluation (about 35% of total patients)

  • Total percentage of more than 25% tumor reduction in chemotherapy alone is 17.0% compared to 28.9% in combined chemotherapy and CDA-II. This shows that the combined chemotherapy and CDA-II is 70% more effective than chemotherapy alone.
  • Total percentage of more than 50% tumor reduction in chemotherapy alone is 10.6% compared to 19.3% in combined chemotherapy and CDA-II. This shows that the combined chemotherapy and CDA-II is 82% more effective than chemotherapy alone.
  • Total percentage of patient deterioration in chemotherapy alone is 21.3% compared to 12.5% in combined chemotherapy and CDA-II.
  • Total percentage of stabilized tumor without significant size reduction is almost the same in both (chemotherapy is only 5% better than the combined therapy). Average percentage of stabilized tumor is 60%.

    Below pictures are 6 patients with CDA-II inventor biochemist, Dr. Ming C. Liau in the last batch of 3rd clinical trial.

    Update (June, 2002) on the mid-term third clinical trial of CDA-II

    Below are the CT scans of some patients in the recently completed mid-term third clinical trials recovered from CDA-II therapy combined with chemotherapy. Visit this webpage again for more results of the clinical trials.

    Patient #1:Male, 39 years old, lung cancer, left scan was taken 2/6/02 when CDAII + NP treatment started. Right scan was taken on 3/20/02 after the treatment. Tumor completely disappeared after the treatment, considered complete recovery.

    Patient #2, male, 46 years old, lung cancer, left scan was taken 11/2/01 when CDAII + MVP treatment started. Middle scan was taken on 12/24/01 which showed reduction in tumor size. Right scan was taken on 2/20/02 showing the tumor about 40% of the original size before the treatment, considered partial recovery. Note: partial recovery indicated 50% or more tumor size reduction.

    Patient #3, female, 58 years old, breast cancer. Left scan was taken on 1/22/02 when CDA-II + NP treatment started, tumor size 6.0 x 2.5 cm. Right scan was taken on 3/18/02 after 2 treatments, considered partial recovery.

    Patient #4, female, 46 years old, breast cancer, metastasized to liver after surgery. Left scan was taken on 1/7/02 when CDA-II + NP treatment started. Middle scan was taken on 3/11/02, right scan taken on 5/6/02. Tumor size was reduced, considered partial recovery.

    Next patient

    POLYMVA Therapy in USA
    (Use back arrow to return here if there is no return link)

    Although my wife had only taken a week of PolyMVA before she passed away and didn't have the chance to receive its benefit, I am very glad to see there are now so many testimonials of using it to control the cancer. I sincerely hope the list will continue to grow. http://www.polymvasurvivors.com/testimonials.html (Use "Back" arrow to return here).

    After 30 years of hardwork and some 20,000 trials of selecting the right metal to react with the lipoic acid, Dr. Merrill Garnett finally found the metal palladium (chemical symbol Pd) to react with lipoic acid to form the Lipoic Acid Palladium complex (LAPd). In 1995 Dr. Garnett patented this nontoxic chemotherapeutic agent targeting only the malignant cells. This compound is now commonly called PolyMVA, where Poly indicates multi-component, MVA stands for minerals, vitamins, and amino acids. For technical discussion and the history of PolyMVA, the readers can read the book written by Dr. Garnett "First Pulse", published by First Pulse Projects, New York, 1998, ISBN: 0-9665597-0-3.

    POLYMVA is an oral medicine physically similar to an ordinary cough syrup. It is nontoxic and easy to use. Presently it is considered to be a nutritional supplement. The patient can view their website for more information.
    PolyMVA website (Use back arrow to return here if there is no return link).

    (Use back arrow to return here if there is no return link)

    Gerson Therapy is a truly nutritional treatment for cancer as well as other metabolic diseases. It has three equally important procedures that have to be performed simultaneously. The first is the detoxification by coffee enemas. The second is the supply of essential nutrients including enzymes from daily 13 glasses of fresh vegetable and fruit juices, and the soup and salad in regular meals. The third is the supplement of potassium, iodine, thyroid hormones, vitamin B3, and some others. The aim of the therapy is to restore the diseased cells to normal condition.

    In addition to above procedures, Gerson Therapy requires a low-sodium, low-sugar, low-protein, low-fat, high-potassium diet. The sugar and salt should come from natural foods, not from refined sources. In general, almost all types of fresh organic vegetables and fruits are encouraged. Tobacco, alcohol, all kinds of processed foods are prohibited. The only oil acceptable in the diet is the flaxseed oil. There are three food categories in Gerson Therapy: desirable, occasionally allowed, and prohibited. The desirable includes all fruits and vegetables plus potatoes and oatmeal, except those listed under prohibited. The occasionally allowed includes breads made from whole rye, oat, or rice flour, unsalted and fat-free popcorn, brown or wild rice, yams and sweet potatoes, honey, raw brown sugar. There are some very occasionally allowed foods not to be consumed more than twice monthly. They include frozen vegetables, sprouted beans or seeds, except alfafa sprout. The prohibited foods include the following:

    Prohibited Foods in Gerson Therapy

  • All processed foods such as those that are bottled, canned, frozen, preserved, refined, salted, smoked, or sulfured (except as specifically mentioned as being allowed) are forbidden.

  • Dairy products of all types such as milk and milk products (including goat's milk) are forbidden. These prohibited items include cheese, cream, ice cream, ice milk, butter, and buttermilk, except as specifically allowed under proteins. Dairy products are generally extremely high in fat. Cheeses may be 65 percent fat and high in sodium. The commcreial buttermilks are "cultured" (produced from leftover milk, flavored, and thickened) and contain fat and sodium. When protein is prescribed, however, fresh, churned buttermilk without any additives may be taken after the sixth to twelfth week of healing. Unsalted, nonfat Quark is premitted when available.

  • Alconhol should not be imbibed because it limits the blood's alility to carry oxygen and places strain on the liver to deloxify and remove it from the body. Alcohol is toxic.

  • Pineapples and berries may cause an allergic reaction to the aromatic acids present.

  • Avocados are too high in fats.

  • Cucumbers in combination with the required juices to be taken daily are diffcult to digest.

  • Spices such as black pepper or papnka are irritants. Basil, oregano, and others are to be avoided because of their high aromatic acid content. Cayenne pepper, jalapenos, and so on are also irritants and can stop the healing.

  • Soybeans and soy products including tofu, tempeh, miso, tamari, other soy sauces, Bragg's Liquid Aminos, textured vegetable protein, soy milk, and all other soy-based products are disallowed. For a variety of different reasons including their high fat content, high sodium content. toxic inhibition to nutrient absorption, and/or elevated protein content, use of soy in all its forms must be avoided.

  • Dried beans and legumes should not be used.

  • Sprouted Alfalfa and Other Bean or Seed Sprouts are high in L-canavanine, an immature amino acid that is responsible for immune system suppression. Also, patients with no prior history of chronic joint pain have developed the sudden onset of arthritic symptoms upon ingesting alfalfa sprouts. Healthy monkey have developed lupus erythematosus from alfalfa sprouts in their diet.

  • Oils and fats of all kinds, with the exclusion of fresh, raw, organic flaxseed oil, are forbidden.

  • Refined white and brown sugars are forbidden.

  • Flour is forbidden.

  • Beef, pork, poultry, eggs, fish, seafood, and all other meat or animal flesh products are prohibited. These animal foods are high in protein, chemicals, perservatives, hormones, and salt and are difficult to digest, often have too much fat, and make additional work for the body's Iiver and excretory systems.

  • Black tea, green tea, and other nonherbal or caffeine-containing teas are forbidden because of their undesirable aromatic acids and caffeine content. Dr. Gerson cited aromatics as interfering with healing by producing allergic reactions (see above as listed under pineapples and berries).

  • Candy, cakes, muffins, pastries, and other refined sweets are prohibited because they contain health-threatening ingredients, such as fats, oils, refined sugars or flours, salt, soda, baking powder, or dairy products. Note, however, that some breads and pastries may be baked using permitted ingredients which will make the diet more interesting but must not be consumed on a regular basis:

  • The drinking of water is not encouraged. Dr. Gerson believed that a Gerson Therapy patient should not drink water, because it dilutes the stomach acid and doesn't allow maximum gastrointestinal tract capacity for nutrition from fresh foods and juices. The juices provide adequate fluids.

  • Mashrooms are not vegetables but fungi and contain complex proteins and are difficult to digest and offer little nutrition.

  • Coffee and coffee substitutes by mouth, both with caffeine and decaffeinated, cause umdesirable stimulation of the digestive system. Orally taken caffeine overly excites the central nervous system, while the essential oils disturb digestion. In contrast, when coffee is taken rectally, it offers an entirely advantageous efect on the liver where, aside from detoxification, it increases the production of glutathione S-transferase (a desirable enzyme).

  • Nuts and seeds, including almonds, apricot kernels, sunflower seeds, flaxseeds, peanuts, cashews, and all other nuts and seeds, are prohibited because they are too high in protein and fat. In "roasting" salt is added, the fat is altered, and nuts and seeds become more harmful.

  • Hot peppers (jaiapenos, ele) contain the same strong aromatics found in prohibited spices. Peppers tend to inhibit healing responses and should be avoided. Green, yellow, and sweet red peppers may be used without limitation.

  • Mustard and carrot greens.

  • Baking powder and baking soda contain sodium and alum (aluminum), which are highly toxic. Aluminum-free and sodium-free baking powder such as Featherweight (potassium-based powder) may be used occasionaily.

  • Fluoride components that are part of any item at all such as water, toothpaste. mouthh gargle, hair dyes, beauty parlor permanents, cosmerics, underarm deodorants. Iipstick, and lotions must be avoided under any conditions.

    Details of Gerson Therapy and diet can be found in the book "The Gerson Therapy", by Charlotte Gerson and Morton Walker, Kensington Publishing, 2001.

    Gerson Therapy Testimonials

    Web Link to Gerson Therapy

    More Gerson Therapy will be shown here

    (Use back arrow to return here if there is no return link)
    Web Links to Hoxsey Therapy

    Chapter 4 of the book by Harry Hoxsey, You Don't Have To Die"

    Assessment of Outcomes at Alternative Medicine Cancer Clinics: A Feasibility Study of Hoxsey and Livingston Therapies

    * * * * * * * * * * * * * * * * * * * *

    Margaret Griffin (lymphosarcoma)

  • Abstracted from the book "When Healing Becomes a Crime" pp20-23, by Kenny Ausubel, 2000, to contact author, email kenny@bioneers.org (website www.bioneers.org)
  • November, 1966, first diagnosed lymphosarcoma, followed by 30 treatments of cobalt radiation, was given a year to live. Took Hoxsey tonic from a doctor who worked at Hoxsey clinic in Texas before the clinic was driven to Tijuana. Ten months after taking the Hoxsey tonic, X-ray showed that the 2 tumors around the aorta had disappeared.
  • After disappearance of tumor, continue taking Hoxsey tonic for 8 years and then intermittently since, also followed prescribed Hoxsey diet.
  • to date, 2000, at the age of 79, Thirty four years after the ocurrence of cancer, is still living free of cancer.

    Gwen Scott (breast cancer)

  • Abstracted from the book "When Healing Becomes a Crime" pp23-26, by Kenny Ausubel, 2000, to contact author, email kenny@bioneers.org (website www.bioneers.org)
  • Some time in 1993, first felt a lump on the breast, but negative biopsy. Eight months later, diagnosed to have a deadly breast cancer with lymph involvement.
  • August, 1994, surgery of lumpectomy and mastectomy, followed by Tamoxifen, expected by the doctor to have only one year to live.
  • After the surgery in 1994, contacted Hoxsey clinic in Tijuana and started Hoxsey therapy.
  • to date, 2000, still living free of cancer.

    Rex Major (colon cancer)

  • Abstracted from the book "When Healing Becomes a Crime" pp26-28, by Kenny Ausubel, 2000, to contact author, email kenny@bioneers.org (website www.bioneers.org)
  • September, 1993, first diagnosed Duke's C cancer of the colon, metastasized involving 4 lymph nodes.
  • Late 1993, surgery after diagnosis, declined chemotherapy suggested by the doctor.
  • After the surgery, Hoxsey therapy in Tijuana.
  • to date, 2000, still living free of cancer.

    Martha Bond (malignant melanoma)

  • Abstracted from the book "When Healing Becomes a Crime" pp28-31, by Kenny Ausubel, 2000, to contact author, email kenny@bioneers.org (website www.bioneers.org)
  • Early 1979, first diagnosed malignant melanoma, declined conventional treatment, went directly to Hoxsey clinic in tijuana.
  • April, 1979, started Hoxsey therapy,
  • 1986, still living free of cancer 7 years after the Hoxsey therapy (such melanoma usually has one year survival rate)
  • After 1986, lost contact.

    More Hoxsey Therapy will be shown here


    Another treatment which the cancer patients should not forget is the vitamin C therapy. It should not be called a therapy. It is best used as a supplemental treatment to the cancer therapy that is being used, whether conventional or alternative. Every cancer patient should read the book "Cancer and Vitamin C" by Ewan Cameron and Linus Pauling, updated and expanded, 1993, Camino Books. There are many case histories of the use of vitamin C to treat cancer at the Vale of Leven Hospital in Scotland. Here are some anecdotal case histories of using vitamin C in cancer treatment from
    Cameron and Pauling (use "Back" arrow to return here)
    Hoffer and Pauling (use "Back" arrow to return here)

    More High dose vitamin C will be shown here


    Integrated Traditional Chinese Medicine (Integrated TCM) is a marriage between the TCM and the conventional cancer treatments (surgery, radiation, chemotherapy). It combines the aggressive killing of cancer cells by the conventional radiation and chemotherapy and the quick recovery of the normal cells killed and the enhancement of the immune system suppressed by the conventional therapies. The combination has been proven very successfully in China, and I hope the western orthodox medical authority will pay attention to this combination treatment and integrate it into our health insurance system. I also hope that Integrated TCM will include the western alternative therapies in the future.

    I invited 3 integrated TCM specialists, Dr. Wen-Xia Huang, Dr. Ming Zhang, and Miss Yehua Shen, a postgraduate research assistant of Dr. Huang, to come to Los Angeles for 2 weeks to share their integrated TCM experience with the local TCM herbalists and conventional oncologists at the end of August, 2003 (Integrated TCM interview in Shanghai, March, 2003) (Use "Back" arrow to return here). They were also invited by the Cancer Control Society to participate and give a presentation of the use of TCM in treating cancer in China in the 31st Annual Cancer Conference from August 30 to September 1, 2003.

    More information on Integrated TCM Therapy and testimonials will be included here in the future.

    32 Western Herbs Against Cancer

    Source of Reference:
  • Ralph W. Moss, Herbs against Cancer, Equinox Press, Inc., 1998, ISBN 1-881025-40-3
  • Ingrid Naiman, Cancer Salves, Seventh Ray Press, 1999, ISBN 1-55643-270-4
  • Jonathan Hartwell, Plants Used Against Cancer, A compilation for National Cancer Institute in 1981, published by Quarterman Publishing in 1982, (out of print now).
  • Hoxsey tonic formula
  • Essiac tea formula
    Following are 32 herbs that have been used in North America and Western herbal medicine against cancer. These 32 herbs are given both in common and scientific Latin name.

    1 barberry (berberis vulgaris)
    2 black nightshade (solanum nigrum)
    3 blood root (sanguinaria canadensis)
    4 burdock (arctium lappa)
    5 cascara (cascara amarga)
    6 cat's claw (uncaria tomentosa)
    7 celandine (chelidonium majus)
    8 chaparral (larrea mexicana)
    9 chinese corydalis (corydalis spp)
    10 dandalion (taraxicum officinale)
    11 duckweed (lemna spp)
    12 false bittersweet (celastrus scandens)
    13 goldenseal (hydrastis canadensis)
    14 guaiacum wood (guaiacum officinale)
    15 juniper berris (juniperus communis)
    16 knotted figwort (scrophullaria nodosa)
    17 licorice (glycyrrhiza)
    18 mayapple (podophyllum peltatum)
    19 pau d'arco (tabebuia avellanedae)
    20 persimmon (diospyros virginiana)
    21 poke (phytolacca decandra / americana)
    22 prickly ash (zanthoxylum spp)
    23 red clover (trifolium pratense)
    24 rhubarb (rheum palmatum)
    25 rock rose (heliathemum canadense)
    26 sheep sorrel (rumex acetosella)
    27 slippery elm (ulmus fulva)
    28 stillingia (stillingia sylvatica)
    29 tag alder (alnus serruleta)
    30 violet (violet spp)
    31 yarrow (achillea millefolium)
    32 yellow dock (rumex crispus)

  • More Testimonials
    Note: Use Back Arrow to Return Here
  • PolyMVA Testimonials
  • Burzynski Antineoplastons Testimonials
  • Gerson Therapy Testimonials
  • 52 "Incurables" That Were Cured By Gerson Therapy
  • Binzel Nutritional Therapy Testimonials
  • Vitamin C (Pauling, Cameron, and Hoffer) Testimonials
  • Chinese TianXian Herbal Testimonials
  • Flax Oil Testimonials
  • An Email From A Recovered Liver Cancer Patient

  • More links to other cancer victors from Cancer Cure Foundation
  • More links to other cancer victors from Home Cancer Page


    Check the following website of California Health Freedom Organization for AB2393 Bill to allow alternative cancer treatments in California. Proposed Health Freedom Bill AB2393 to Allow Alternative Cancer Treatments in California

    Note: This weblink seems to be disconnected at present (April 29, 2004), check again in the future.

    Cancer Related Websites
    Note: Use Back Arrow to Return Here

  • http://www.polymva.com/ (PolyMVA therapy)
  • http://www.hoxsey.com/ (Hoxsey herbal therapy)
  • http://www.essiac-info.org/ (Essiac herbal therapy)
  • http://www.everlife.com.cn/ (Cell differentiation therapy)
  • burzynski_clinic (Antineoplaston therapy)
  • burzynski_clinic patient group (Antineoplaston therapy support group)
  • http://www.gerson.org/ (Gerson therapy)
  • http://http://www.zbwk.com/ (Beijing Chinese herbal therapy)
  • http://www.tianxian.com/ (Chinese herbal therapy)
  • http://www.cerbe.com/ (Naessens method and 714-X)
  • http://www.williamfkoch.com/ (Work of Dr. Koch and his glyoxylide)
  • http://www.handpen.com/Cancell/cancell.htm#Main (Cancell therapy)
  • http://www.orthomed.com/ (Vitamin C in cancer treatment and orthomolecular medicine)
  • http://www.iptq.com/ (Insulin potentiation therapy)
  • http://members.aol.com/pbchowka/index.html (Peter Chowka home page)
  • http://www.rifetechnology.com/ (Rife technology, Dan Tunney, Canadian researcher and manufacturer )
  • http://www.electroherbalism.com (Turf's Electroherbalism)
  • http://www.drhuldaclark.org/ (Hulda Clark therapy)
  • http://groups.yahoo.com/group/DrClark-testimonials/messages/1/ (Hulda Clark therapy testimonials)
  • http://www.cancure.org/ (Cancer Cure Foundation including clinics in U.S., Mexico and others)
  • http://www.allhealth.com/ (Cancer patients support)
  • http://www.medicalmailbox.com/alternative_medicine.htm (Information in alternative medicine)


    Translated by Stanley Cua, PhD, from the book "CDA-II, The Smart Cancer Drug" by Dr. Ming C. Liau, 1999 originally in Chinese


    From the time I was born in 1935, until 1962 when I went to graduate school in America, I had been living in Taiwan. During this period of time, there were two wars, one the second world war and the other against Chinese communists. My life was very unstable and was almost always in poverty. I had to study very hard so that I could go abroad for higher education , which was the dream of every young adult of my time. At that time the person who influenced me most was Dr. Yugawa Hideki of Japan, a Nobel prize laureate, who said that he was not born a genius, but that his hard working was many more times that of others. His words adhered permanently in my mind and has become my lifetime principle.

    Because of my hard work in school, I was honored the second highest in the entire school when I graduated from high school. I was also honored the second highest place in the entire Taiwan University in my first year at the university. Taiwan University was the best university in Taiwan, and the students were among the best in the country. For me to be in the second place, I must have been studying extremely hard.

    When I was still young, I saw the agony and suffering of a relative who died of cancer, and had a strong adverse feeling against cancer. On the other hand, I didn't feel bad when I saw another relative died of stroke at about the same time. I promised myself to do my best to eradicate cancer when I grew up, and I have since then direct my study towards this goal.

    I selected Pharmacy as my major study in Taiwan University. Antibiotics were at its best at that time. Antibiotic drugs were the drugs of choice because they were very selective in eliminating the bacteria in the host. They killed the bacteria with only minor side reactions. On the other hand, chemotherapeutic drugs for cancer killed the cancer cells as well as the normal cells indiscriminately and had many side effects. Selectivity is a very important requirement of an effective drug. Drug without selectivity such as chemotherapeutic drugs for cancer is not a good drug. But unlike bacteria cells and human cells which are very different, to find a drug that can distinguish cancer cells from normal cells in one's own body is not easy because cancer cells differs only slightly from normal cells. Nevertheless, the drug that can distinguish cancer cells from normal cells must be found. From the first time I encountered Pharmacy, I already had a feeling that the fundamental difference between cancer cells and normal cells must be found, else we would never develop an effective drug for cancer.

    What is the fundamental difference between cancer cells and normal cells ? This question has always been in my mind, and it has steered the direction of my research. After graduating from college, I continued to do research in the field of biochemistry at Taiwan University, because biochemistry is the branch of science that is most related to finding the difference between cancer cells and normal cells. I worked under Professors Shu Chian Tian and Tong Ee Tze on the unique composition of cancer cells and the anticancer components of Abrus precartrins, I began to learn cancer disease. After I finished my degree in Biochemistry Department, Professor Shu started and headed the Taipei Medical College. I lectured in that Medical College for a year before applying for higher education abroad. Professor Shu encouraged me to pursue study abroad and hoped that I would come back to teach in the Medical College. I never expected that I would stay in the United States for 32 years before returning to Taiwan, and by that time Professor Shu had already passed away. I missed him so much.

    Before 1962, master degree was the highest educational degree in Taiwan. To pursue higher degree would have to go abroad. I applied to Professor Harris Busch of the Baylor College of Medicine in Texas, and was accepted with scholarship. The economy of the United States in the early 1960s was very prosperous, and it was easy to get scholarship in graduate school. I arrived in the United States in the autumn of 1962 to start the research career I had always dreamed of. In Taiwan, I could only obtain the knowledge of research facilities in textbooks. In America, they were all around the university's science and technology departments. I was immediately totally absorbed in the research environment. It was the era of rapid development of molecular biology. I had a thirst for new knowledge, and was frequently working day and night in my laboratory. Searching for new discovery became my only enjoyment. My research topic was the separation and structural composition of nucleoli. In less than 6 months I already had a publishable paper. Professor Busch had many interests, he was interested in anything related to the nucleus of living cells. There were many people working for him. With more than 500 papers published up to 1989, he could be the most prolific producer of scientific papers in America. He particularly emphasized efficiency in work, "the faster the better" was his motto. Publishing scientific papers and excellent skill in oral communications made him very influential in American Cancer Society. He was once the president of the Society.

    I didn't stay long in Professor Busch's laboratory. When I first joined him, he was the chairman of both Biochemistry Department and Pharmacology Department. After six months, the school invited a new head for the Biochemistry Department. The new department head gave me two choices: either to change my major to pharmacology or stay in biochemistry but choose a new adviser. I had more interest in biochemistry and decided to choose a new adviser in Biochemistry Department. My decision made Professor Busch unhappy, which had bad consequence in my future career. My new adviser, Dr. Robert B. Hurlbert, and Professor Busch both came from University of Wisconsin under Professor Van R. Potter. Professor Potter was an authority in biochemistry. Although I didn't study or work under him, his thinking had influenced me deeply. He believed that the disruption of cell differentiation is the main problem of cancer. I completely agreed with his belief. My new adviser, Dr. Hurlbert and my previous adviser, Professor Busch were two different personalities. Dr. Hurlbert was more conservative and persistent. He worked out pyrimidine pathway as a graduate student at a time when the metabolism of glucose and energy conversion were the main stream, and he continued this line of research in his career. Professor Busch was more flexible. He followed the current trend in his research direction. My personality was closer to Dr. Hurlbert, and that was one of the reasons I chose him as my adviser. I like to work under Dr. Hurlbert because he didn't insist on his students to follow his footstep. This gave me the freedom to follow my own interest and belief in my research work. Otherwise, I would have been like all others trying to look for the impossible answer in the wrong direction by following the footstep of the adviser.

    Strong ability to synthesize ribosome is a characteristic property of cancer cells. The formation of ribosome is a required step in cell replication. I liked to know if there is any difference in the synthesis of ribosome between cancer and normal cells. My research in Dr. Hurlbert's laboratory was directed towards the study of RNA synthesis in isolated nuclei and nucleoli of cancer and normal cells. I also tried to find out the regulatory factors in the synthesis of RNA and the purification of its synthesizing enzymes. Everything went very smoothly, and I completed my PhD degree in three years. However, I was disappointed with the results, because the enzyme that synthesizes RNA was not a factor in cancer growth.

    After I received my PhD degree in 1966, I went to Philadelphia Cancer Research Institute to continue for my post doctorate research under Dr. Robert P. Perry. The size of the research institute was small (less than 100 staffs), but the research staffs were among the top-notch quality. Two were Nobel prize winners, and seven were members of the National Academy of Science, and Dr. Perry was one of them. The northeast of the United States had been the center of scientific development. Communication of new information was extremely fast. It was no wonder the center of new scientific discoveries. Dr. Perry had multitude of different research interests, sometimes in ribosome, sometimes in messenger ribonucleic acid, sometimes in methylation of nucleic acid, and sometimes in other unrelated topics such as the regulation of the formation of antibody, but his research topic was always at the forth front of science. He was an unpredictable type of scientific genius. When I joined him, he was concentrating on the regulation of ribosome formation. I worked in this area for two years, basically the work was pure science research, because Dr. Perry was not eagle to find the solution to cancer. Nevertheless, I learned the importance of the methylation of nucleic acid, and I directed my energy and attention in that area.


    I accepted the position of Assistant Professor at the University of Texas M. D. Anderson Hospital and Tumor Institue in 1968. I could then do independent research and pursue my dream of finding a cure to cancer. M. D. Anderson was the largest cancer research institute in America. Texans liked to be big, and its cencer research facility had also to be the biggest. At that time applying for the research funding was not easy because of the huge expenses in Vietnam war. I only got a nominal funding from the American Cancer society. In 1971, President Nixon announced the war on cancer, research funding became very much abundant and available. I got research grants both from National Cancer Institute and Welch Foundation.

    I continued to make new discoveries, and the results were published in the most authoritative publications. 1968 to 1980 were my best years. I proved that methyltransferase was the most sensitive factor in the regulation of the ribosome formation. I also discovered that methylation process was accomplished by a complex from three enzymes, namely, methionine adenosyltransferase (MAT), methyltransferase (MT), and S-adenosylhomocysteine hydrolase (SAHH). The regulatory function of this complex is very different between cancer cells and normal cells. The activity of this complex in normal cells is completely dependent on external factor, which is growth factor. When the external growth factor is present, the complex is very active and the cells replicate; when growth factor is absent, the complex becomes inactive and the cells are diverted into differentiation pathway. On the other hand cancer cells produce their own internal "growth factor" as a specific protein factor that sustains the high activity of the complex, which enables the cells to continuously replicate and blocks terminal differentiation. The alteration of this complex by the specific protein factor produced in cancer cells is the central problem of cancer.

    The value of Km of normal MAT is significantly different from that of altered MAT, hence it is easy to detect the altered MAT by simply measuring the Km value. All of the cancer tissues that I had analyzed had mutated MAT. Apparently the alteration of the aboved-mentioned ternary enzyme complex was the common denominator in cancer. The MAT was never found abnormal in normal cells, even those that had fast replication rate. It could therefore be concluded that the abnormal ternary enzyme complex was a characteristic property of cancer cells. This was exactly what I had been looking for. I always believed that if we cannot find the basic difference between cancer and normal cells, we can never solve cancer problem. I originally assumed that this basic difference should be a factor that could broadly affect the metabolism of the cells. The factor responsible for the abnormality of MAT affects all other methylation processes. This factor fits nicely into my assumption. Methylation regulates the formation of ribosome, which is a necessary modification for the function of mRNA and tRNA, and a very important factor in the regulation of gene expression. I believed that I had found the key to the basic cause of cancer. But to convince others of the theory that I had developed in 1980 was very difficult, because the methylation of DNA was not clear at that time. The ability of methyl radical to affect the expression of some genes was only slowly appreciated after 1985.

    After knowing the cause, it was much easier to find the solution. I discovered after treating liver cancer cells with poly(I)(C) the altered ternary complex was first normalized, and after a while, the formation of nucleic acid and protein was reduced, and finally the cells stop to replicate. This was my discovery in 1975. The inhibition of cell replication by Poly(I)(C) was identical in principle to the induction of terminal differentiation of cancer cells by interferon or retinoic acid. Therefore in 1975 I already established prototype of differentiation therapy, although the terminology of differentiation therapy was not known yet at that time. I believed that the induction of differentiation by these agents was mediated through oligoisoadenylate in normalizing the ternary enzyme complex. In other words, oligoisoadenylate and CDA-II has the same effect. Oligoisoadenylate is a very special compound of adenylic acids, made up of three adenylic acids. The altered ternary enzyme complex in cancer cells are especially sensitive to this type of compounds. On the other hand, the normal ternary enzyme complex is not affected. Hence this type of compounds has selectivity in the inhibition of cancer. Theoretically I had discovered that the inhibitors of abnormal cancer methylation enzymes could selectively inhibit cancer, but before I could find a cell differentiation agent that could be tested clinically, I had to stop my research work, because my funding was cut off.

    Mid l970s were the period of most abundant funding in cancer research. My research work was very innovative and important, and my publications were numerous, why was my funding cut off? It was because of one of my publications that contradicted the view of both my doctorate advisor, Professor Harris Busch, and my post doctorate advisor, Dr.Robert Perry. Before l975, there was a controversy in the relative positions of the smaller and larger rRNA genes. Some researchers believed the larger gene to be in the front (i.e., ribonucleic acid 5' side), Professor Busch was one of them. I had a very good way of finding out the correct positions in this controversy. The distribution of methyl groups in these two rRNA is quite different, and thus can be used to distinguish these two rRNA sequences. I introduced radioactive methyl groups into newly formed nascent chains, and then separate them into two parts according to their chain length, and finally analyzed the distribution of methyl groups in these two parts. My finding was that the smaller gene was in the front and the larger gene in the rear position, which was the opposite of Dr. Busch's result. At about the same time, Dr. Perry published a paper that was also the opposite of my finding. I published a paper with a conclusion simultaneously contradicting two of my advisers, which was an unforgivable sin. My renewal application of American Cancer society grant in l975 was cut off, because the review panel concluded that I was creating controvery. God knows that I was trying to reconcile, not to create, a controversy that had already existed. Three years later, my research funded by National Cancer Institute was also cut off. This research was about methylation enzymes that had nothing to do with the controversy. In addition, Dr. Perry has published another paper correcting his own mistake, but it was to no avail. I was never able to get another research grant again. Although I still had the support of the Welch foundation, I was fired nonetheless. At the year of my highest creativity, l980, I left M.D. Anderson Hospital & Tumor Institute, terminating my l2 years of assistant and associate professorship. My dream of finding a cure for cancer also vanished.

    God had not let me down, I soon found a new job at the Burzynski Research Institute as the chairman of the biochemistry department. The Institute was founded by Dr. Burzynski, who was 8 years younger than I was. He immigrated into America in l970 and worked as an assistant professor at Baylar College of Medicine. He later founded the Burzynski Research institute in l978. Originally he was in the research of peptides in the blood, and later found that these peptides had anti-cancer properties, and was since then involved in anti-cancer research. Urine has similar anti-cancer peptides, he then extracted these peptides from the urine and called them "antineoplastons". He used antineoplastons to treat cancer patients and obtained unusually good responses. He became known for his success in treating cancer patients with antineoplastons. When I joined him in the latter part of l980, it was one of his best years. A large group of cancer patients heard about him and came to be treated, nobody including FDA interfered with his work. Not too long after I joined him, the media was very interesed in his unorthodox approach to cancer. NBC broadcasted nationwide an interview with him. He was young and successful at that moment and made some remarks that criticized and antagonized the medical establishments. From then on, we had basketful of troubles and never lived a peaceful day again. FDA was always at our back requiring all sorts of documentations. I had to spend 4 years to organize all the paper work to satisfy the requirements, such as manufacturing process and quality control of antineoplastons. Court cases began to appear. There was at least one big case every 3 years that could destroy him and his research. The case in l997 was the biggest of all, with 75 counts that could send him to jail for 99 years. Actually his license could be revoked and his cancer treatment terminated even with only one count. Why would the government, especially FDA, want him to be in jail was beyond comprehension. But Dr. Burzynski was very lucky, he never lost a single case. It was probably not just luck, but his success in the treatment that saved so many cancer patients who were all behind him and rallying in front of the court house in all those cases. If not for those cancer patients he saved, he would have been annihilated long time ago.

    I was with Burzynski for l4 years, most of the time we were struggling just to be alive. When I first joined him, his financial situation was very good, he bought a lot of laboratory equipment and instruments to let me do the research. But later, his financial resources were depleted. There was one time he even borrowed $5,000 from me to meet the emergency. I could not do much in research under that kind of condition. His financial difficult started to improve after l985, I was then able to spend more time in research. I then discovered that his antineoplastons could solve altered ternary methylation enzymes I discovered. How could this be so coincidental? I began to believe that I was sent by the God to solve the cancer problem, because these anti-cancer agents were given to us at birth from our God. I started to rekindle the fire of discovering cancer cure inside me, and went back to my busy research.

    I concentrated all of my energy into the search for the anti-cancer agents in the urine, from separation and purification to the theory of their anti-cancer action. I discovered that the urine contained three major anti-cancer agents: cell differentiation inducing agents, cell differentiation helper inducing agents, and an anti-cachexia agent. Cachexia is caused by infection resulting in the over-excretion of low molecular weight metabolites in the urine. Low molecular weight metabolites in the urine contain the anti-cancer agents. Chronic infection can usually lead to cancer because of the presence of cachectin that depletes the anti-cancer agents in the urine. These three anti-cancer agents in the urine work synergistically against cancer, which results in the most effective inhibition of cancer. At this time, the function of the DNA methylation was already recognized, and the inability of the stem cells or cancer cells to express differentiation related genes was due to the presence of methyl groups in the promoter of these genes. Therefore for these genes to express, it must go through the synthesis of hypomethylated DNA. The altered ternary methylation enzymes in the cancer cells are too active, which is the reason that cancer cells can not undergo differentiation. If cancer cells are treated with the anti-cancer agents of the urine, the altered ternary methylation enzymes will be inhibited,and the cancer cells can go through the synthesis of hypomethylated DNA to trigger differentiation to reach a state that cancer cells are no longer capable of dividing. I finally completed my fundamental theory of cell differentiation therapy. I also established the hypothesis of chemical surveillance in our body, explaining why we all have anti-cancer agents in our body, and yet some can still get cancer. These theoretical bases could explain the logics of using the urine extract in cancer treatment, but they never had the opportunity to be recognized in the United States. The U.S. medical authority never gave me a chance to publish my discovery and theory. I was deeply fraustrated. Even until now 4 years after dissociation from Burzynski Research Institute in l994, my paper and thesis in these areas that involved only synthetic compounds, which had nothing to do with the urine, were all rejected by the medical publishers in the U.S. The antagonism of the U.S. medical authority towards me is really deep-rooted.


    In l993, the oncologist of Chang Gung Hospital in Taiwan, Dr. Gi Ming Lai, went to America to see me through the introduction of a relative. He had a very important cancer patient who had tried every chemotherapeutic drug without success, and had to turn to alternative therapy. This was a typical example, a very important cancer patient, going through the best chemotherapy with very good initial response, sometimes to the point of complete remission, but later the drug-resistant cancer cells appear and no chemotherapeutic drug can stop the progression, even the alternative therapy. Patients who reached this stage could not be saved. However, I could help other patients who had not reached this stage. He detected that I was not happy with my life in the United States, and invited me to go to Taiwan to start a new life. Dr. Lai was the first orthodox-trained physician I had encountered who was not against unorthodox treatment. If there were more oncologists like him, cancer problem might have already been solved. I was very fraustrated at that time, so I accepted his invitation and returned to Taiwan next year. Dr. Lai introduced me to an early investor in China, Mr. Hoger Y. S. Chang and an enterpreneur Mr. Ringo M. L. Chang. Later these two enterpreneurs together with me and some of their friends incorporated a new "Everlife Pharmaceutical Corporatioon".Mr. Hoger Chang and I went to Hefei, Anhui province in China, to build the factory. There was no relative and friend to keep us company in that isolated place, and we had to endure the hardship and loneliness day after day. Quite often, the pictures that came to my mind were the Su Wu tending the sheeps after he was captured by the nomad in China, our ancestors in Taiwan exploring the wilderness, and Deng Xia Ping pacing in his backyard when he was ousted by Mao Ze Tong. I started to train my endurance, jogging 3 kilometers everyday. All these sufferings were for the objective of "removing the suffering of patients from cancer disease, and building a better tomorrow". That was my ideal, and also the ideal of Everlife Pharmaceutical Corporation.

    I redesigned the manufacturing process, and my good friend from America, Dr, Shih San Lee came to help me. In the September of l995, the first batch of cell differentiation agent, CDA-II, was produced. We immediately requested Dr. Xu Bo Shou of Anhui Medical University to conduct a clinical trial to observe if there was any toxicity or side effect. Previous pre-clinical studies have been conducted and have shown the drug to be quite safe. It should not have side effect. Clinical trials verified that there was no toxicity, but had a mild side effect of blood vein irritation during the injection. Fortunately among the cancer patients in the initial clinical trials, two had very good responses, one was a non-Hodgkin's lymphoma patient who had regressed for 3 years without recurrence. The other was a lung cancer patient treated in combination with radiation therapy, who had also regressed for 3 years without recurrence. The initial clinical trials in Anhui Medical University established the safety and efficacy of CDA-II.

    Our general manager, Mr. Hoger Y. S.Chang, although a lay person in cancer field, studied very hard and collected many information concerning urine therapy against cancer. We then found Dr. K. Sano in Japan using urine therapy to treat cancer patients with good results. I thought of cooperating with him, and went to Japan in March of l966 to talk with him. Two months later in May, we invited him and another very famous urine therapist in Japan, Dr. Ryoichi Nakao, to come to Taiwan to conduct seminars in urine therapy. It was a very successful event, and we continued to cooperate closely. Dr. Sano was a genius in the use of CDA-II. He combined it with vitamins Bl7 and C, which he used previously in combination with his urine therapy, and the results were extremely good. Without question, CDA-II was a good anti-cancer agent. In only 4 short years, we have attained the success of today. The full support of our board chairman, Mr. Ringo M. L. Chang, was the most important factor. He only wanted to do something good for the people, and had put in more investment than anticipated. Without him our dream could not have come true.

    Above translation has been read and corrected by Dr. Liau (Stanley)

    Return to the top

    * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

    Message from Stanley Cua (updated 4/24/04) ...

    I am hosting this website in memory of my loving wife Josefina O. Cua who passed away on February 28, 2001, after 6 years of fight against leukemia and almost 3 years against metastasized colon cancer. Josefina had worked for Los Angeles County for almost 10 years. She was loved by her friends and everyone who had personal contact with her because of her enthusiasm in helping others. I would like to continue her legacy of loving and helping people through the wonderful world of Internet.

    This website will collect and present the stories of long-term cancer survivors who have won the battle against cancer so that a new cancer patient can learn from their experiences in the search for the best treatment.

    This website will try to build a database of the long-term cancer survivors with a concise and uniform format that the new patients can use to compare their cases with those of long-term survivors. It gives new cancer patients the comfort of knowing so many long-term survivors of similar cases, and the strength and confidence to continue the fight. The testimonials of cancer patients in China, either personal or cited from the books and other publications, will be included in the Chinese version of Brave-Souls.com

    This is a long-range project. It may take years to have a good database that can help cancer patients to make the best choice of their treatment. I wish to invite the long-term cancer survivors to participate in this website bysending their stories. I would also like very much to link up with other websites that the same objectives.

    The third clinical trial of CDA-II has recently been approved by the Chinese government, which means that both intravenous and oral forms of CDA-II will be available commercially. Cancer patients can now be treated with CDA-II in any hospital or clinic in China. CDA-II will probably be available before August, 2004. For cancer patients outside of China, special arrangement may be made with some clinics or hospitals in Tijuana, Mexico, one of them at present is International Bio Care Hospital (IBC Hospital). For Chinese patients or others who would like to be treated in China, Contact me at pinacua@aol.com if I can be of any assistance.

    In the past several decades China has been using "Integrated TCM" therapy, which is a combination of conventional surgery, radiation, chemotherapy, and Traditional Chinese Medicine (TCM). In this Integrated TCM therapy, Chinese herbs were used before, during and after the conventional treatment. Acupuncture was also used if necessary. Experience revealed that adding Chinese herbs before and during the conventional treatment could reduce the side effects and potentiate the conventional treatment. Furthermore, using Chinese herbs after the conventional treatment could reduce the recurrence of the cancer. In some instances, purely Traditional Chinese Medicine without conventional treatment were able to control the cancer.

    This website will disseminate the experience of Chinese oncologists in the use of pure TCM and Integrated TCM in the past several decades.

    The latest alternative cancer treatment using POLYMVA in the United States is gaining momentum. More testimonials are being presented. POLYMVA is an oral medicine physically similar to an ordinary cough syrup. Like all the cancer drugs, both conventional and alternative, any specific drug may be effective for some, but not for some others, the patient has to try it out to find out. In this case, the patient can try out for a few weeks, if it shows sign of controlling or reversing the cancer, the patient can continue to use, otherwise, this oral medication can be stopped any time. It is considered to be a nutritional supplement, and no toxicity has been reported. The patient can view their website for more information.
    Polymva website (Use back arrow to return here if there is no return link).

    Gerson Therapy is one of the best alternative cancer treatments that I know of. Although it is not easy to implement outside of the clinics accredited by the Gerson Institute, it can be the last hope for those who have no one and nowhere else to turn to. For this reason, I will place as much as possible information on the self-implementation of Gerson Therapy that may save the patients. However, I would recommend strongly that the patients purchase and read the book "The Gerson Therapy" by Charlotte Gerson and Morton Walker, 2001, Kensington Publishing Corp.

    Gerson Therapy and many other nutritional treatments of cancer are not only good for cancer, but for many other metabolic diseases. The diets that they recommend for cancer patients are generally ideal for ordinary people. I have decided to devote a section of the website "Nutritional and Herbal Approach to Better Health" to aim at the prevention of fatal diseases.

    * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

    Return to top of the page

    * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *


    In Memory of Josefina O. Cua

    By Woon Lim, Supervising Appraiser, Los Angeles County Assessor Office

    I have fought the good fight, I have finished the race, I have kept the faith. Now, a crown is waiting for me. These words could be Josefina Cua , an Appraiser in Region 5, who succumbed to her battle with cancer on February 28, 2001.

    Josefina was born on December 22, 1950 in Manila, Philippines.  She graduated magna cum laude with a Bachelor of Science in Mathematics.  While a student in college, she also taught school part time.  In 1972 she married Stanley Cua, a chemical engineer in Region 30.  They came to the United States in 1985. Stan credits Josefina for creating and maintaining a loving, nurturing home for their three children.

    Josefina joined Los Angeles County in 1990 as a clerk in the Pasadena office.  In 1997 she was accepted into Appraiser Training Class 56.  To those of us who were fortunate enough to have worked closely with Josefina, she was more than a colleague, she was a dear and beloved friend.  She was kind, generous, and extremely considerate.  She would go out of her way to help others and never expect anything in return.  Even during her illness, she still made time for her family, friends, and coworkers.  She never complained about her troubles, but was always an encouragement to those she came into contact with, including those she met while undergoing her cancer treatment.

    She was the best coworker anyone could have asked for.  She was conscientious, cooperative and willing to carry more than her fair share of the workload.  She was a constant inspiration to us all.  All of us who knew her will miss her very much, but her loving and caring acts will linger fondly in our memories.

    Reprinted from The Valuator, Vol 4, No 3, March, 2001, published by Los Angeles County Office of The Assessor.

    Return to top of the page

    Stanley Cua, Founder of Brave-Souls.com Contact: pinacua@aol.co

    0 0 0 0 0
    0 0 0 0 0
    0 0 0 0 0
    0 0 0 0 0

    You are visitor #

    (after viewing the websites below, click "Back" arrow to return here)

    staytuned.ws (alternative health treatments) asktheinternettherapist.com(internet cancer therapists) apjohncancerinstitute.org(cancer research institute) Other website links
    (links in Resources webpage)

    Speak with Surviving Cancer Patients for Help and Support

    Find long-term cancer survivors of similar case.

    Contact them, they are willing to share their experiences with you.



    Stanley Cua
    Contact Email:  pinacua@aol.com

    Disclaimer:  Brave-Souls.com does not in any way give professional medical advice.  This is a support website for cancer patients who wish to contact cancer survivors for advice, resources, or friendship.  Resources available at this website are for recommendation only.  Thank you for visiting.  Please contact Stanley Cua with any questions or concerns at:  pinacua@aol.com
    Website Created and Designed by:
    Online Success for Internet Business

    © Copyright 2001-2002 Brave-Souls.com